Precision medicine for pediatric and adolescent acute leukemia

Description of the granted funding

The treatment of acute leukemia in children and adolescents is lenghty and causes a wide variety of short- and long-term adverse events. Moreover, despite intensive treatments, some patients experience a relapse. In this research project, we aim to elucidate the detailed mechanisms of acute leukemia by which the disease arises and resists therapies. Based on these findings, we seek novel precision therapies, especially for patients with a high risk for disease relapse. The research is being conducted together with many international collaborations and utilizes animal models of leukemia and drug screening settings in addition to cell culture models and patient samples.
Show more

Starting year

2021

End year

2025

Granted funding

Olli Lohi Orcid -palvelun logo
242 911 €

Funder

Research Council of Finland

Funding instrument

Clinical researcher

Other information

Funding decision number

341540

Fields of science

Biomedicine

Research fields

Biolääketieteet

Identified topics

cancer